April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
A Cell-Specific Proteomic Approach to Astrocyte Responses in Experimental Glaucoma
Author Affiliations & Notes
  • Gulgun Tezel
    Ophthalmology & Visual Sciences,
    Anatomical Sciences & Neurobiology,
    University of Louisville, Louisville, Kentucky
  • Xiangjun Yang
    Ophthalmology & Visual Sciences,
    University of Louisville, Louisville, Kentucky
  • Cheng Luo
    Ophthalmology & Visual Sciences,
    University of Louisville, Louisville, Kentucky
  • Jian Cai
    Pharmacology & Toxicology,
    University of Louisville, Louisville, Kentucky
  • David W. Powell
    Biochemistry & Molecular Biology,
    University of Louisville, Louisville, Kentucky
  • Footnotes
    Commercial Relationships  Gulgun Tezel, None; Xiangjun Yang, None; Cheng Luo, None; Jian Cai, None; David W. Powell, None
  • Footnotes
    Support  NEI grants (R01 EY013813, R01 EY017131, R24 EY015636), and RPB
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3098. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gulgun Tezel, Xiangjun Yang, Cheng Luo, Jian Cai, David W. Powell; A Cell-Specific Proteomic Approach to Astrocyte Responses in Experimental Glaucoma. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3098.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : While RGCs and their axons are specific victims of glaucoma, assessing astrocyte responses is equally important to better understand glaucomatous neurodegeneration. This study aimed to introduce and validate a new technique to study astrocyte-specific responses.

Methods: : IOP elevation was induced in rats by hypertonic saline injections into episcleral veins. Enriched samples of astrocytes were isolated through the two-step immunomagnetic cell selection process originally established to enrich RGC samples. To select astrocytes, the macrophage-depleted retinal cell suspension obtained from the first step was incubated with magnetic beads bound to a monoclonal ASTRO1 antibody in the second step. Ocular hypertensive and control samples were collected by pooling from eyes matched for the cumulative IOP exposure. Protein expression was analyzed by a label-free quantitative technique using 2D-LC-MS/MS. Bioinformatic data analysis utilized the Ingenuity Pathways Analysis.

Results: : When first tested by Western blot analysis using specific antibodies, GFAP expression was detectable, but neuronal markers (including NeuN and Thy-1.1) were undetectable in enriched samples of astrocytes. 2D-LC-MS/MS analysis of these samples identified hundreds of proteins with high confidence (based on at least two identified peptides and a greater than 99.0% probability assigned by the Protein Prophet algorithm). The MS/MS data verified GFAP expression and also presented numerous low abundant signaling molecules. Astrocyte proteins exhibiting an over two-fold increased expression in ocular hypertensive samples included those involved in energy metabolism, molecular transport, protein synthesis/folding, cellular growth/proliferation, cell structure/cytoskeleton, free radical scavenging, cell signaling, cell-cell interaction, and antigen presentation/immune response. Bioinformatic comparison analysis with the parallel RGC-specific data supported differential responses of different cell types during the experimental paradigm (stress response and cell death signaling in RGCs versus cellular activation response in astrocytes).

Conclusions: : These findings validate the sensitivity of an astrocyte-specific proteomic approach. By dissecting the complexity of prior data obtained from whole tissue, this pioneering approach will enable specific responses of astrocytes to be defined and new treatment strategies targeting glial cells to be developed.

Keywords: proteomics • astrocyte • neuroprotection 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.